Register for Upcoming Webinar on DEC. 8 @ 11AM

2024 China NMPA Bluebook is here:

China Mandatory Period Risk Evaluation Report and the latest PMS Requirements in NMPA and FDA

  • Version
  • Download 72
  • File Size 0.00 KB
  • File Count 1
  • Create Date July 9, 2020
  • Last Updated September 30, 2022

China Mandatory Period Risk Evaluation Report and the latest PMS Requirements in NMPA and FDA

Did you know China, the second-largest medical device and in vitro diagnostic (IVD) industry market globally, is the only market with a 20 percent annual growth rate year after year?

Are you up to speed on the hundreds of new regulations introduced by China’s National Medical Products Administration (NMPA) — formally known as the China Food and Drug Administration?

What are the strategic factors to consider during the reform before your submission?

Attached Files

FileAction
DmvhOfBZsKcDownload